138 related articles for article (PubMed ID: 15041312)
21. The impact of cyclosporine on the development of immunosuppressive therapy: perspective from a transplant nephrologist involved with the development of C2.
Cole E; Deshpande R
Transplant Proc; 2004 Mar; 36(2 Suppl):408S-413S. PubMed ID: 15041376
[TBL] [Abstract][Full Text] [Related]
22. The clinical impact of 1:1 conversion from Neoral to a generic cyclosporine (Gengraf) in renal transplant recipients with stable graft function.
Qazi YA; Forrest A; Tornatore K; Venuto RC
Clin Transplant; 2006; 20(3):313-7. PubMed ID: 16824147
[TBL] [Abstract][Full Text] [Related]
23. [Controversies about the use of calcineurin inhibitors in pediatric patients].
Dello Strologo L
G Ital Nefrol; 2008; 25(3):317-24. PubMed ID: 18473303
[TBL] [Abstract][Full Text] [Related]
24. [The evolution of immunosuppression in clinical kidney transplantation: the experience of 700 cases].
Alfani D; Bruzzone P; Bachetoni A; Berloco P; Caricato M; Casciaro G; Cinti P; Iappelli M; Marciani A; Poli L
G Chir; 1991; 12(6-7):362-6. PubMed ID: 1751323
[TBL] [Abstract][Full Text] [Related]
25. An open randomized study comparing immunosuppression therapy initiated before or after kidney transplantation in haploidentical living recipients.
Câmara NO; Dias MF; Pacheco-Silva A
Clin Transplant; 2004 Aug; 18(4):450-5. PubMed ID: 15233825
[TBL] [Abstract][Full Text] [Related]
26. Use of cyclosporine in renal transplantation.
Kyriakides G; Miller J
Transplant Proc; 2004 Mar; 36(2 Suppl):167S-172S. PubMed ID: 15041330
[TBL] [Abstract][Full Text] [Related]
27. Single-center experience with cyclosporine therapy for kidney transplantation: analysis of a twenty-year period in 1200 patients.
Snanoudj R; Kriaa F; Arzouk N; Beaudreuil S; Hiesse C; Durrbach A; Charpentier B
Transplant Proc; 2004 Mar; 36(2 Suppl):83S-88S. PubMed ID: 15041313
[TBL] [Abstract][Full Text] [Related]
28. Ten years of cyclosporine use in renal transplantation: a single-center experience with 479 renal transplants.
Lucan M; Iacob G; Lucan C; Lăpuşan C; Munteanu A; Sîrbu S
Transplant Proc; 2004 Mar; 36(2 Suppl):177S-180S. PubMed ID: 15041332
[TBL] [Abstract][Full Text] [Related]
29. Is acute rejection the key predictor for long-term outcomes after renal transplantation when comparing calcineurin inhibitors?
Nashan B
Transplant Rev (Orlando); 2009 Jan; 23(1):47-52. PubMed ID: 19027616
[TBL] [Abstract][Full Text] [Related]
30. Variable cyclosporine exposure: a risk factor for chronic allograft nephropathy and graft loss?
He X; Johnston A
Transplant Proc; 2004 Jun; 36(5):1321-6. PubMed ID: 15251323
[TBL] [Abstract][Full Text] [Related]
31. Five-year study of tacrolimus as secondary intervention versus continuation of cyclosporine in renal transplant patients at risk for chronic renal allograft failure.
Jevnikar A; Arlen D; Barrett B; Boucher A; Cardella C; Cockfield SM; Rush D; Paraskevas S; Shapiro J; Shoker A; Yilmaz S; Zaltzman JS; Kiberd B
Transplantation; 2008 Oct; 86(7):953-60. PubMed ID: 18852662
[TBL] [Abstract][Full Text] [Related]
32. Neoral C2 monitoring in solid organ transplantation.
Levy GA
Transplant Proc; 2004 Mar; 36(2 Suppl):392S-395S. PubMed ID: 15041373
[No Abstract] [Full Text] [Related]
33. Monitoring C2 level predicts exposure in maintenance lung transplant patients receiving the microemulsion formulation of cyclosporine (Neoral).
Jaksch P; Kocher A; Neuhauser P; Sarahrudi K; Seweryn J; Wisser W; Klepetko W
J Heart Lung Transplant; 2005 Aug; 24(8):1076-80. PubMed ID: 16102443
[TBL] [Abstract][Full Text] [Related]
34. Minimization of immunosuppressive therapy and immunological monitoring of kidney transplant recipients with long-term allograft survival.
Pretagostini R; Cinti P; Lai Q; Poli L; Berloco PB
Transpl Immunol; 2008 Nov; 20(1-2):3-5. PubMed ID: 18773959
[TBL] [Abstract][Full Text] [Related]
35. Cyclosporine--lessons from the first 20 years.
Cortesini R
Transplant Proc; 2004 Mar; 36(2 Suppl):158S-162S. PubMed ID: 15041328
[TBL] [Abstract][Full Text] [Related]
36. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
Schulz T; Kapischke M; Busing M
Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
[TBL] [Abstract][Full Text] [Related]
37. Two decades of experience with cyclosporine in renal transplantation in Helsinki.
Salmela KT; Kyllönen LE
Transplant Proc; 2004 Mar; 36(2 Suppl):94S-98S. PubMed ID: 15041315
[TBL] [Abstract][Full Text] [Related]
38. Sirolimus: mammalian target of rapamycin inhibitor to prevent kidney rejection.
Cowan PA; Heizer KE
Nephrol Nurs J; 2000 Dec; 27(6):623-5. PubMed ID: 16649344
[TBL] [Abstract][Full Text] [Related]
39. Stable kidney function in the second decade after kidney transplantation while on cyclosporine-based immunosuppression.
Kandaswamy R; Humar A; Casingal V; Gillingham KJ; Ibrahim H; Matas AJ
Transplantation; 2007 Mar; 83(6):722-6. PubMed ID: 17414704
[TBL] [Abstract][Full Text] [Related]
40. Single-center, open, prospective, randomized pilot study comparing cyclosporine versus tacrolimus in simultaneous pancreas-kidney transplantation.
Boggi U; Vistoli F; Del Chiaro M; Croce C; Morelli L; Coletti L; Signori S; Giannarelli R; Marchetti P; Del Prato S; Rizzo G; Mosca F
Transplant Proc; 2004 May; 36(4):1064-6. PubMed ID: 15194369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
